The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia
NCT ID: NCT03667729
Last Updated: 2018-09-12
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
75 participants
Study Classification
INTERVENTIONAL
Study Start Date
2014-06-30
Study Completion Date
2015-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study applied a randomized parallel case-controlled design. The study purpose was to evaluate the effects of progressive muscle relaxation on anxiety, psychiatric symptoms and quality of life among patients with chronic schizophrenia compared with an active control.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Progressive Muscle Relaxation on Psychological Symptoms and Mental Well-Being in Patients With Schizophrenia
NCT05324865
Schizophrenic Psychoses
UNKNOWN
NA
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483
Cognitive Therapy
UNKNOWN
NA
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia
NCT04917302
Schizophrenia
RECRUITING
PHASE2
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201
Schizophrenia
RECRUITING
PHASE2
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
NCT04503954
Schizophrenia
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Background: Anti-psychotic drugs are limited in their ability to improve psychiatric symptoms, quality of life, and anxiety status in patients with chronic schizophrenia. Progressive Muscle Relaxation (PMR) can potentially reduce anxiety status and improve subjective welling in acute patients. It is an ideal rehabilitation intervention for patients with chronic schizophrenia. However, no study has investigated the effects of PMR on outcomes among patients with chronic schizophrenia.
Design: This study applied a randomized parallel case-controlled design.
Methods: Hospital-based randomized control trial in Taiwan. Eighty subjects with chronic schizophrenia were recruited from a psychotic ward and randomized into PMR, or control groups. Patients in the intervention group participated in progressive muscle relaxation for 12 weeks; while patients in the control group members received supportive treatment-as-usual (TAU). All participants completed anxiety, psychotic syndromes and quality of life measures at baseline, 3-month, and 3-month follow-up.
Design: This study applied a randomized parallel case-controlled design.
Methods: Hospital-based randomized control trial in Taiwan. Eighty subjects with chronic schizophrenia were recruited from a psychotic ward and randomized into PMR, or control groups. Patients in the intervention group participated in progressive muscle relaxation for 12 weeks; while patients in the control group members received supportive treatment-as-usual (TAU). All participants completed anxiety, psychotic syndromes and quality of life measures at baseline, 3-month, and 3-month follow-up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Affective Disorders
Psychotic Disorder
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
This study applied a randomized parallel case-controlled design.
Hospital-based randomized control trial . Subjects were chronic schizophrenia who were recruited from a psychotic ward complex and randomized into PMR, or control groups.
Hospital-based randomized control trial . Subjects were chronic schizophrenia who were recruited from a psychotic ward complex and randomized into PMR, or control groups.
Primary Study Purpose
SUPPORTIVE_CARE
Blinding Strategy
SINGLE
Outcome Assessors
The rater did not know what interventions the participants belonged to.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
progressive muscle relaxation
The experimental group received PMR once a week for a total of 12 weeks. Subjects completed measures at baseline, 3-month, and 3-month follow-up.
Group Type
EXPERIMENTAL
progressive muscle relaxation
Intervention Type
BEHAVIORAL
intervention group: The experimental group received muscle relaxation training once a week for 3 consecutive months. The results were measured and followed up after 3 months.
Control group
treatment-as-usual(TAU)
Group Type
NO_INTERVENTION
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
progressive muscle relaxation
intervention group: The experimental group received muscle relaxation training once a week for 3 consecutive months. The results were measured and followed up after 3 months.
Intervention Type
BEHAVIORAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of Schizophrenia
* Without the risk of self-injury and violence
* Patients aged from 20-65 years old
* Had no alcohol and drug abuse
* Can use Mandarin or Taiwanese to communicate
* Without the risk of self-injury and violence
* Patients aged from 20-65 years old
* Had no alcohol and drug abuse
* Can use Mandarin or Taiwanese to communicate
Exclusion Criteria
* Patients with another psychiatric comorbidity
* Patients with musculoskeletal problems
* patients who cannot sit last for 50 minutes
* Had received progressive muscle relaxation training within the last year
* Diagnosis of confirmed cardiovascular disease
* Patients with musculoskeletal problems
* patients who cannot sit last for 50 minutes
* Had received progressive muscle relaxation training within the last year
* Diagnosis of confirmed cardiovascular disease
Minimum Eligible Age
20 Years
Maximum Eligible Age
65 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hsiu-ju Chang, PHD
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University
References
Explore related publications, articles, or registry entries linked to this study.
Bernstein, D. A., & Borkovec, T. D. (1973). Progressive Relaxation Training: A Manual for the Helping Professions.
Reference Type
BACKGROUND
SpielBerger C. (1983). Manual for the state-trait anxiety inventory. Palo Alto, CA: Consulting Psychologists Press.
Reference Type
BACKGROUND
Hedlund, J. L. & Vieweg, B. W. (1980) The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. Journal of Operational Psychiatry, 11, 48- 65.
Reference Type
BACKGROUND
Bernstein, D. & Borkove, c. T. (1973). Progressive relaxation training. Champaign, IL: Research Press.
Reference Type
BACKGROUND
Overall, J.E., Gorham, D.R., 1962. The brief psychiatric rating scale. Psychol. Rep. 10, 799e812.
Reference Type
BACKGROUND
Overall, J.E., 1974. The brief psychiatric rating scale in psychopharmacology research. In: Pichot, P., Olivier-Martin, E. (Eds.), Psychological Measurements in Psychopharmacology: Modern Problems in Psychopharmacology. Karger, Basel, Switzerland, pp. 67e78.
Reference Type
BACKGROUND
Ben-Zeev D, Larson J, Sarratt M. A possible role for Progressive Muscle Relaxation in the treatment of persecutory ideation. Med Hypotheses. 2010 Dec;75(6):568-71. doi: 10.1016/j.mehy.2010.07.033. Epub 2010 Aug 14.
Reference Type
RESULT
Bebbington PE, Angermeyer M, Azorin JM, Marwaha S, Marteau F, Toumi M. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia. Acta Psychiatr Scand Suppl. 2009;(438):22-8. doi: 10.1111/j.1600-0447.2008.01310.x.
Reference Type
RESULT
Achalia RM, Chaturvedi SK, Desai G, Rao GN, Prakash O. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia. Asian J Psychiatr. 2014 Jun;9:31-5. doi: 10.1016/j.ajp.2013.12.010. Epub 2014 Jan 4.
Reference Type
RESULT
Chino B, Nemoto T, Fujii C, Mizuno M. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia. Psychiatry Clin Neurosci. 2009 Aug;63(4):521-8. doi: 10.1111/j.1440-1819.2009.01995.x. Epub 2009 Jun 15.
Reference Type
RESULT
Cramer H, Lauche R, Klose P, Langhorst J, Dobos G. Yoga for schizophrenia: a systematic review and meta-analysis. BMC Psychiatry. 2013 Jan 18;13:32. doi: 10.1186/1471-244X-13-32.
Reference Type
RESULT
Erol A, Delibas H, Bora O, Mete L. The impact of insight on social functioning in patients with schizophrenia. Int J Soc Psychiatry. 2015 Jun;61(4):379-85. doi: 10.1177/0020764014548287. Epub 2014 Sep 1.
Reference Type
RESULT
Georgiev A, Probst M, De Hert M, Genova V, Tonkova A, Vancampfort D. Acute effects of progressive muscle relaxation on state anxiety and subjective well-being in chronic Bulgarian patients with schizophrenia. Psychiatr Danub. 2012 Dec;24(4):367-72.
Reference Type
RESULT
Hartley S, Barrowclough C, Haddock G. Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms. Acta Psychiatr Scand. 2013 Nov;128(5):327-46. doi: 10.1111/acps.12080. Epub 2013 Feb 4.
Reference Type
RESULT
Harvey PD, Loewenstein DA, Czaja SJ. Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia. Neurobiol Dis. 2013 May;53:18-25. doi: 10.1016/j.nbd.2012.10.022. Epub 2012 Oct 31.
Reference Type
RESULT
Holubova M, Prasko J, Hruby R, Latalova K, Kamaradova D, Marackova M, Slepecky M, Gubova T. Coping strategies and self-stigma in patients with schizophrenia-spectrum disorders. Patient Prefer Adherence. 2016 Jun 24;10:1151-8. doi: 10.2147/PPA.S106437. eCollection 2016.
Reference Type
RESULT
Hunter R, Barry S. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment. Eur Psychiatry. 2012 Aug;27(6):432-6. doi: 10.1016/j.eurpsy.2011.02.015. Epub 2011 May 23.
Reference Type
RESULT
Jeyagurunathan A, Vaingankar JA, Abdin E, Sambasivam R, Seow E, Pang S, Picco L, Chong SA, Subramaniam M. Gender differences in positive mental health among individuals with schizophrenia. Compr Psychiatry. 2017 Apr;74:88-95. doi: 10.1016/j.comppsych.2017.01.005. Epub 2017 Jan 12.
Reference Type
RESULT
Karow A, Wittmann L, Schottle D, Schafer I, Lambert M. The assessment of quality of life in clinical practice in patients with schizophrenia. Dialogues Clin Neurosci. 2014 Jun;16(2):185-95. doi: 10.31887/DCNS.2014.16.2/akarow.
Reference Type
RESULT
Karpov B, Joffe G, Aaltonen K, Suvisaari J, Baryshnikov I, Naatanen P, Koivisto M, Melartin T, Oksanen J, Suominen K, Heikkinen M, Paunio T, Isometsa E. Anxiety symptoms in a major mood and schizophrenia spectrum disorders. Eur Psychiatry. 2016 Sep;37:1-7. doi: 10.1016/j.eurpsy.2016.04.007. Epub 2016 Jul 21.
Reference Type
RESULT
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-76. doi: 10.1093/schbul/13.2.261.
Reference Type
RESULT
Lecardeur L. [The quality of life in schizophrenia]. Encephale. 2015 Sep;41(4):373-8. doi: 10.1016/j.encep.2015.07.001. Epub 2015 Sep 2. French.
Reference Type
RESULT
Li Y, Hou CL, Ma XR, Zhong BL, Zang Y, Jia FJ, Lin YQ, Lai KYC, Chiu HFK, Ungvari GS, Hall BJ, Cai MY, Ng CH, Xiang YT. Quality of life in Chinese patients with schizophrenia treated in primary care. Psychiatry Res. 2017 Aug;254:80-84. doi: 10.1016/j.psychres.2017.04.049. Epub 2017 Apr 24.
Reference Type
RESULT
Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017 Feb;16(1):14-24. doi: 10.1002/wps.20385.
Reference Type
RESULT
Margariti M, Ploumpidis D, Economou M, Christodoulou GN, Papadimitriou GN. Quality of life in schizophrenia spectrum disorders: associations with insight and psychopathology. Psychiatry Res. 2015 Feb 28;225(3):695-701. doi: 10.1016/j.psychres.2014.11.016. Epub 2014 Nov 15.
Reference Type
RESULT
Mas-Exposito L, Amador-Campos JA, Gomez-Benito J, Lalucat-Jo L. The World Health Organization Short Disability Assessment Schedule: a validation study in patients with schizophrenia. Compr Psychiatry. 2012 Feb;53(2):208-16. doi: 10.1016/j.comppsych.2011.02.009. Epub 2011 Apr 12.
Reference Type
RESULT
McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76. doi: 10.1093/epirev/mxn001. Epub 2008 May 14.
Reference Type
RESULT
Mingrone C, Rocca P, Castagna F, Montemagni C, Sigaudo M, Scalese M, Rocca G, Bogetto F. Insight in stable schizophrenia: relations with psychopathology and cognition. Compr Psychiatry. 2013 Jul;54(5):484-92. doi: 10.1016/j.comppsych.2012.12.014. Epub 2013 Jan 15.
Reference Type
RESULT
Muller DJ, Chowdhury NI, Zai CC. The pharmacogenetics of antipsychotic-induced adverse events. Curr Opin Psychiatry. 2013 Mar;26(2):144-50. doi: 10.1097/YCO.0b013e32835dc9da.
Reference Type
RESULT
Oliveira SE, Carvalho H, Esteves F. Toward an understanding of the quality of life construct: Validity and reliability of the WHOQOL-Bref in a psychiatric sample. Psychiatry Res. 2016 Oct 30;244:37-44. doi: 10.1016/j.psychres.2016.07.007. Epub 2016 Jul 8.
Reference Type
RESULT
Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry. 2004 Jan;161(1):53-8. doi: 10.1176/appi.ajp.161.1.53.
Reference Type
RESULT
Pelka M, Kolling S, Ferrauti A, Meyer T, Pfeiffer M, Kellmann M. Acute effects of psychological relaxation techniques between two physical tasks. J Sports Sci. 2017 Feb;35(3):216-223. doi: 10.1080/02640414.2016.1161208. Epub 2016 Mar 21.
Reference Type
RESULT
Rofail D, Regnault A, le Scouiller S, Berardo CG, Umbricht D, Fitzpatrick R. Health-related quality of life in patients with prominent negative symptoms: results from a multicenter randomized Phase II trial on bitopertin. Qual Life Res. 2016 Jan;25(1):201-11. doi: 10.1007/s11136-015-1057-9. Epub 2015 Jul 5.
Reference Type
RESULT
Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S, Malaspina D, Owen MJ, Schultz S, Tsuang M, Van Os J, Carpenter W. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013 Oct;150(1):3-10. doi: 10.1016/j.schres.2013.05.028. Epub 2013 Jun 22.
Reference Type
RESULT
Tsou JY. Natural kinds, psychiatric classification and the history of the DSM. Hist Psychiatry. 2016 Dec;27(4):406-424. doi: 10.1177/0957154X16656580. Epub 2016 Jul 4.
Reference Type
RESULT
Vancampfort D, Correll CU, Scheewe TW, Probst M, De Herdt A, Knapen J, De Hert M. Progressive muscle relaxation in persons with schizophrenia: a systematic review of randomized controlled trials. Clin Rehabil. 2013 Apr;27(4):291-8. doi: 10.1177/0269215512455531. Epub 2012 Jul 27.
Reference Type
RESULT
Vancampfort D, De Hert M, Knapen J, Maurissen K, Raepsaet J, Deckx S, Remans S, Probst M. Effects of progressive muscle relaxation on state anxiety and subjective well-being in people with schizophrenia: a randomized controlled trial. Clin Rehabil. 2011 Jun;25(6):567-75. doi: 10.1177/0269215510395633. Epub 2011 Mar 14.
Reference Type
RESULT
Vancampfort D, De Hert M, Knapen J, Wampers M, Demunter H, Deckx S, Maurissen K, Probst M. State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study. Disabil Rehabil. 2011;33(8):684-9. doi: 10.3109/09638288.2010.509458. Epub 2010 Aug 18.
Reference Type
RESULT
Vancampfort D, Probst M, Helvik Skjaerven L, Catalan-Matamoros D, Lundvik-Gyllensten A, Gomez-Conesa A, Ijntema R, De Hert M. Systematic review of the benefits of physical therapy within a multidisciplinary care approach for people with schizophrenia. Phys Ther. 2012 Jan;92(1):11-23. doi: 10.2522/ptj.20110218. Epub 2011 Nov 3.
Reference Type
RESULT
Vera-Garcia E, Mayoral-Cleries F, Vancampfort D, Stubbs B, Cuesta-Vargas AI. A systematic review of the benefits of physical therapy within a multidisciplinary care approach for people with schizophrenia: An update. Psychiatry Res. 2015 Oct 30;229(3):828-39. doi: 10.1016/j.psychres.2015.07.083. Epub 2015 Jul 31.
Reference Type
RESULT
Wang FZ, Luo D, Kanb W, Wang Y. Combined intervention with education and progressive muscle relaxation on quality of life, functional disability, and positive symptoms in patients with acute schizophrenia. J Altern Complement Med. 2015 Mar;21(3):159-65. doi: 10.1089/acm.2014.0128. Epub 2015 Feb 11.
Reference Type
RESULT
The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995 Nov;41(10):1403-9. doi: 10.1016/0277-9536(95)00112-k.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C20140205
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Mindfulness-based Illness Management Program for Schizophrenia
NCT01667601
COMPLETED
NA
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
NCT05052853
RECRUITING
PHASE2
tDCS Combined With rTMS for Negative Symptoms of Schizophrenia
NCT05695144
UNKNOWN
NA
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
NCT05240976
RECRUITING
PHASE2
Effects of RAS in SZ
NCT07086040
NOT_YET_RECRUITING
NA
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
NCT02850445
UNKNOWN
NA
Resourcefulness Group Intervention on Recovery and Quality of Life
NCT06206798
COMPLETED
NA
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
NCT06574360
RECRUITING
PHASE2
Effects of Oxytocin on Negative Symptoms and Social Cognition in Schizophrenia and Its Possible Mechanisms
NCT03662425
COMPLETED
NA
Effectiveness of Using Calligraphic Activity to People With Schizophrenia
NCT03882619
COMPLETED
NA
Combined Exercise and PMS: Impact on Biopsychosocial Function in Older Adults With Schizophrenia
NCT07194460
NOT_YET_RECRUITING
NA
Dance/Movement Therapy for Bone Mineral Density in Schizophrenia
NCT05716802
COMPLETED
NA
Monotherapy of an NMDA Enhancer for Schizophrenia
NCT04745143
RECRUITING
PHASE2
Autonomic Nervous System and Meridian Energy in Patients With Schizophrenia
NCT06617104
RECRUITING
Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia
NCT05229484
COMPLETED
NA
Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
NCT04027634
COMPLETED
NA
Aggressive Acts Among Patients With Schizophrenia
NCT00172497
SUSPENDED
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576
COMPLETED
PHASE4
The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With Schizophrenia
NCT01139099
COMPLETED
NA
The Effectiveness of Lower Extremity Strength Training
NCT07183969
COMPLETED
NA
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770
UNKNOWN
Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control
NCT04941677
COMPLETED
Needs-tailored Nurse-led Recovery Program for Community-dwelling People With Schizophrenia
NCT05304780
COMPLETED
NA
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
NCT05542212
UNKNOWN
NA
Effect of Hot Footbath on the Sleep Quality
NCT04703530
COMPLETED
NA